新入荷
再入荷
Frontiers | A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk
4.1
（1件）
タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料（※）
999円以上お買上げで代引き手数料無料
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
商品詳細情報
| 管理番号 |
新品 ：6380188441
中古 ：6380188441-1 |
メーカー | 65c09b41315a | 発売日 | 2025-03-12 15:43 | 定価 | 11300円 | ||
|---|---|---|---|---|---|---|---|---|---|
| カテゴリ | |||||||||
Frontiers | A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk
Frontiers | A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk,The Scientific and Clinical Potentials of Imaging Cytotoxic T-Cells Using Zr-89 Crefmirlimab Berdoxam | Journal of Nuclear Medicine,18F-FDG PET/CT in left ventricular assist device infections: In-depth characterization and clinical implications - The Journal of Heart and Lung Transplantation,Full body scans miss the mark when it comes to improving U.S. disease prevention : r/medicine,Nuclear Molecular Imaging for Evaluating T Cell Exhaustion | Molecular Pharmaceutics,
健康・医学の作品リスト
![検証 コーヌスクローネ [新品]](https://static.mercdn.net/item/detail/orig/photos/m37685762848_1.jpg)
レディースの製品
